The measurement and clinical relevance of brain atrophy in multiple sclerosis.
about
Regional white matter atrophy--based classification of multiple sclerosis in cross-sectional and longitudinal dataFingolimod in the treatment of relapsing-remitting multiple sclerosis: long-term experience and an update on the clinical evidenceOptimizing treatment success in multiple sclerosisThe effect of disease modifying therapies on brain atrophy in patients with relapsing-remitting multiple sclerosis: a systematic review and meta-analysisPharmacological Approaches to Delaying Disability Progression in Patients with Multiple SclerosisFingolimod: direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapyThe topographical model of multiple sclerosis: A dynamic visualization of disease courseThe Direct Effects of Fingolimod in the Central Nervous System: Implications for Relapsing Multiple SclerosisPsychopathology in multiple sclerosis: diagnosis, prevalence and treatmentMetabolic changes in the visual cortex are linked to retinal nerve fiber layer thinning in multiple sclerosisEvidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic processAlemtuzumab Use in Clinical Practice: Recommendations from European Multiple Sclerosis Experts.Clinical use of brain volumetry.Bringing CLARITY to gray matter atrophy.Clinical relevance of brain volume measures in multiple sclerosis.[Ultrahigh field MRI in context of neurological diseases].MRI measures of neurodegeneration in multiple sclerosis: implications for disability, disease monitoring, and treatment.Sub-millimeter imaging of brain-free water for rapid volume assessment in atrophic brains.The role of the cerebellum in multiple sclerosis.Treating relapsing-remitting multiple sclerosis: therapy effects on brain atrophy.Handling changes in MRI acquisition parameters in modeling whole brain lesion volume and atrophy data in multiple sclerosis subjects: Comparison of linear mixed-effect modelsA practical review of the neuropathology and neuroimaging of multiple sclerosis.Estimating Brain Lesion Volume Change in Multiple Sclerosis by Subtraction of Magnetic Resonance Images.Brain atrophy in multiple sclerosis: therapeutic, cognitive and clinical impact.The Relationship Between Brain MR Spectroscopy and Disability in Multiple Sclerosis: 20-Year Data from the U.S. Glatiramer Acetate Extension Study.MRI in multiple sclerosis: what's inside the toolbox?Brain MRI atrophy quantification in MS: From methods to clinical application.Outcome Measures in Clinical Trials for Multiple Sclerosis.MRI in multiple sclerosis: current status and future prospectsVolume and shape in feature space on adaptive FCM in MRI segmentation.Outcome measures in relapsing-remitting multiple sclerosis: capturing disability and disease progression in clinical trials.Two studies in one: A propensity-score-matched comparison of fingolimod versus interferons and glatiramer acetate using real-world data from the independent German studies, PANGAEA and PEARL.Intellectual enrichment is linked to cerebral efficiency in multiple sclerosis: functional magnetic resonance imaging evidence for cognitive reserve.A voxel-based morphometry study of disease severity correlates in relapsing-- remitting multiple sclerosis.Sample size requirements for treatment effects using gray matter, white matter and whole brain volume in relapsing-remitting multiple sclerosisCorrelation between white matter damage and gray matter lesions in multiple sclerosis patients.Advanced MRI in multiple sclerosis: current status and future challengesLongitudinal MR spectroscopy of neurodegeneration in multiple sclerosis with diffusion of the intra-axonal constituent N-acetylaspartate.Microstructural changes in the striatum and their impact on motor and neuropsychological performance in patients with multiple sclerosisCerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosis
P2860
Q24647968-8ED6BAF7-3E09-4DC5-B821-745ADBBB765CQ26752466-92C2E953-4664-4CFE-A2EB-04C8E370D5B5Q26771968-154E50D9-FF8B-43A1-AE85-1A922D889D02Q26824991-7C2153F2-A104-46E5-83E3-75BA9B6725DEQ27000269-D80B038C-0E86-4AD7-AAE6-063F5A0D9B40Q27011473-4FB0DA0C-2C43-4794-92B7-8D6C4E2D1A04Q27312133-9EAC9D0A-BCFD-4056-97A5-864A5DCA3BF7Q28073377-46633269-58FC-42BA-8E51-365B3FA05FF6Q28301691-90FF9036-4CDC-4673-940B-7A891328B305Q28741362-04745F79-F4C5-434C-A175-BA6E404D94B0Q29542960-7F2D9C03-1670-40FB-AA8E-CB82B8E105A5Q30490389-1AA696B9-E8CC-4D0E-B0E8-D13B0AEFAA17Q30582479-65B8D01B-74FA-4AD3-9CEA-549EEA8FD824Q30651109-E2DED0EE-1884-4389-A47F-FDDC89B31463Q30738659-9B3F57FA-EDED-4C2D-8D33-7CA5FD85CB04Q30759627-F09D72D6-E1BF-42D6-BA2F-FFAF4F783B50Q30798662-38210321-D877-4811-8B87-81C13735F4C0Q30832217-44896E0D-3E6B-4F34-A9EB-7878AEA7316EQ30884001-8249453A-B008-4E43-84C9-C91A11117D37Q30965003-F49276D9-9D23-41D7-ACE6-4C3561E992ADQ30982037-FC3F7FFE-9DF0-4B8B-88FD-21315DD750AEQ31062386-1CED168C-818E-4DA6-8A94-6B034288C2E4Q31063913-076325EF-34EA-4845-9AB9-546FA32261D6Q31070072-F53D364F-7994-49A2-9591-1CD151C863E1Q31100010-CB7810BB-B5DD-4DDA-9E4A-778B62F5BCFFQ31132442-43D9CF46-B438-4984-9419-182F9999FC20Q31149648-5E5E2366-8966-40B5-AB01-58B5C016D995Q31160866-4C1B6F79-7B80-42C2-AC29-3565D07953D6Q33345057-6D4D472E-74F1-44F9-A070-D3FB1061F322Q33346051-CB9FCF18-F5B9-4E03-B48C-D93574012253Q33634866-FFF352CF-BDA5-4EA0-9925-E0F142A84E0FQ33642908-7D6E275C-B43D-48AF-AAB7-A09FC557CE33Q33656333-DE101127-C0ED-4EA2-A01E-C4D8D6239982Q33738609-C135B2B1-B541-43D8-97F6-25E33B268802Q33757630-97044EEB-40D6-4529-8F60-DA254DE55A4DQ33771276-D492D672-D634-4556-9B93-C4BB52651407Q33856615-4FA25EC6-3A2D-4ED5-9594-E452764C6E54Q33869743-D0A01FAC-C20C-4E8F-BD7C-82E905B4462DQ33928228-7783593C-99F9-42AD-8090-66F2D90760B7Q34123689-A602720D-5000-4732-B5A6-E900FC888822
P2860
The measurement and clinical relevance of brain atrophy in multiple sclerosis.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The measurement and clinical relevance of brain atrophy in multiple sclerosis.
@ast
The measurement and clinical relevance of brain atrophy in multiple sclerosis.
@en
type
label
The measurement and clinical relevance of brain atrophy in multiple sclerosis.
@ast
The measurement and clinical relevance of brain atrophy in multiple sclerosis.
@en
prefLabel
The measurement and clinical relevance of brain atrophy in multiple sclerosis.
@ast
The measurement and clinical relevance of brain atrophy in multiple sclerosis.
@en
P1433
P1476
The measurement and clinical relevance of brain atrophy in multiple sclerosis.
@en
P2093
Robert A Bermel
Rohit Bakshi
P304
P356
10.1016/S1474-4422(06)70349-0
P577
2006-02-01T00:00:00Z